Swine Flu Vaccine Being Tested by GlaxoSmithKline
GlaxoSmithKline has announced the beginning of testing of its swine flu vaccine on humans.
Press Release Service – Wired PR News – GlaxoSmithKline has reportedly begun to test its swine flu vaccination on human beings. As reported by the Associated Press (AP), the drugmaker made the announcement Friday, citing plans to conduct 16 clinical trials for the vaccine on thousands of individuals in North America and Europe.
Alexandra Harrison, a spokesperson for the company is quoted by the AP as stating of expectations that the vaccine will be on the market soon, despite the trials being scheduled to last for approximately one year, “We aim to get the first doses out in September.” Harrison is further noted to state that the initial trial is being done in Germany.
As noted by the AP, other pharmaceutical companies have begun testing of their own swine flu vaccinations as well.
WiredPRNews.com – The latest in Health News
Photo Credit: Wikipedia: Centers for Disease Control and Prevention
Tags: Drugmaker, Europe, Germany, GlaxoSmithKline, North America, swine flu, Tested, Vaccination, vaccineOnline Health & Fitness News Press Release Distribution - WiredPRNews.com
- FREE Local Childhood Obesity Prevention Program Changes Kids Lives
- New Classification System for Air Filters Homes in on Efficiency, Savings
- Soprano Laser Hair Removal Now More Effective then IPL
- ‘New Year, New You’ Already in Jeopardy, As Brits Quit The Gym!
- Sustainability in the Workplace: Healthier Air, Higher Morale
- High Dose Rate Electronic Radiation Skin Cancer Treatment Now Available in US
- Chicago’s Gold Coast Goes Green As Skin Care Line Opens Flagship Sales Office
- Free Exercise Manual Aims to Reduce Childhood Obesity
- No Texting While Paddling: SUP Eco Adventures Provides THE Alternative
- Sandusky Accusers Get Foundation’s Help
